Lactalis climate engagements validated by SBTi: A Major Step Towards Carbon Neutrality by 2050
Lactalis Group has recently obtained validation of its climate targets from the Science Based Targets initiative (SBTi). This recognition marks a milestone in the company’s commitment to achieving carbon neutrality by 2050, aligning actions with the scientific requirements of the Paris Agreement to limit global warming to 1.5°C above pre-industrial levels. “The Importance of SBTi Validation” The SBTi is an independent […]
Lactalis Ingredients Pharma : A reliable and sustainable source of pharmaceutical lactose made in France
Introduction The pharmaceutical industry faces numerous challenges in sourcing sustainable and reliable ingredients. Drug shortages pose significant issues for healthcare systems worldwide. These shortages can occur for various reasons, including manufacturing problems, quality issues, supply chain disruptions, regulatory challenges, increased demand, and financial constraints. Shortages of active pharmaceutical ingredients (APIs) and excipients due to supply […]
The challenges of sustainable pharmaceutical sourcing
The healthcare sector accounts for 4.4% of the world’s net global greenhouse emissions and 8% of emissions in France.[1] Given this situation, and at a time when sustainability is increasingly becoming a key issue, the pharmaceutical industry has no choice but to go with the flow of sustainable transition. In France, the pharmaceutical association Leem […]
